Status:
UNKNOWN
Montelukast in Children With Wheezing
Lead Sponsor:
Universita di Verona
Collaborating Sponsors:
Azienda Ospedaliera Universitaria Policlinico
Conditions:
Wheezing
Eligibility:
All Genders
6-24 years
Phase:
PHASE4
Brief Summary
In this study children with recurrent wheezing (\>/= 2 episodes in the last 6 months)and aged less than 2 years will be enrolled as outpatients. They will undergo lung function evaluation by Rint and ...
Detailed Description
Patients aged less than 2 years with recurrent wheezing. At visit 1 patients with symptoms will be enrolled and the study explained. They will return home with bronchodilator therapy. Within 1 week t...
Eligibility Criteria
Inclusion
- Age between 6-24 months
- Patients with recurrent wheezing (at least 2 episodes in the last 6 months)
- Patients with symptoms at enrollment
Exclusion
- Chronic respiratory diseases (cystic fibrosis, chronic lung disease) symptoms at visit 1 that require hospital admission
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00775697
Start Date
September 1 2009
End Date
December 1 2014
Last Update
June 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Pediatrica Universita' di Verona Policlinico GB Rossi
Verona, Italy, 37134